A soluble form of ST2 (sST2) is a decoy receptor for IL-33, which blocks the IL-33/ST2 pathway and drives Th2 cells toward a Th1 cell phenotype, and it is thought to be important in the pathophysiology of GVHD [18,19]. The gene discussed is IL33; the disease is graft versus host disease.